Jason Rhodes

Jason Rhodes is on these Sector & Stage Rankings

Jason Rhodes's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Be Biopharma	Series UnknownOct 2024$82M Series BApr 2022$130M Series AOct 2020$52M	$260M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Accent Therapeutics	Series CJan 2024$75M Series BApr 2020$63M Series AMay 2018$40M	$180M
Co-investors: Larry Lasky (The Column Group), Naveen Krishnan (Leaps by Bayer)
K36 Therapeutics	Series BJun 2023$70M Series ADec 2021$30M	$100M
Co-investors: Chong Xu (F-Prime Capital Partners), Melissa McCracken (Nextech Invest)
AAVantgarde Bio	Series AJun 2023$65M	$65M
Co-investors: Paola Pozzi (Soffinova Partners), Graziano Seghezzi (Soffinova Partners), Dmitrij Hristodorov (Forbion), David Steinberg (Longwood Fund)
Rectify Pharmaceuticals	Series AOct 2021$100M	$100M
Co-investors: Marco Boorsma (Forbion), David Steinberg (Longwood Fund), Jodie Morrison (Atlas Venture), Rajesh Devraj (Atlas Venture)
Gemini Therapeutics	Post Ipo EquityFeb 2021$95M Series AOct 2017$43M SeedApr 2016$2M	$140M
Co-investors: Carl Gordon (OrbiMed), Stephen Squinto (OrbiMed), Jean George (Advanced Technology Ventures)
Generation Bio	Series CJan 2020$110M Series AJan 2018$25M	$140M
Third Harmonic Bio	Series AJan 2019$50M	$50M
Co-investors: David Bonita (OrbiMed), Michael Gladstone (Atlas Venture)